Skip to main content

Table 1 Clinical manifestations of systemic sclerosis patients

From: Serum defensin levels in patients with systemic sclerosis

Clinical manifestations N (%)
Lung Involvement 20 (47.6)
Pulmonary hypertension 11 (31.4)
Esophageal involvement 13 (31)
Intestinal involvement 2 (4.8)
Renal involvement 2 (4.8)
Telangiectasia 20 (48.8)
Raynaud’s phenomenon 41 (97.6)
Digital ulcer 16 (36.8)
Autoantibodies
 ANA 42 (100)
 Anti-Scl-70 27 (67.5)
 Anti- centromere 10 (25)
 RNP 0
 SS-A 9 (25.7)
 SS-B 2 (5.7)